Protein binding of carbamazepine in epileptic patients
- 1 April 1982
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 32 (4) , 415
- https://doi.org/10.1212/wnl.32.4.415
Abstract
The degree of protein binding of carbamazepine was evaluated in 45 mentally retarded epileptic patients. Although the mean percent unbound carbamazepine agreed with that obtained elsewhere, a wide interpatient variability was noted. There was a good correlation between unbound carbamazepine and total carbamazepine serum concentrations. The results of this study indicate that the total carbamazepine serum concentration must be interpreted with caution, and the unbound fraction may be a more appropriate therapeutic measure.This publication has 7 references indexed in Scilit:
- Kinetics of carbamazepine and carbamazepine‐epoxide, determined by use of plasma and salivaClinical Pharmacology & Therapeutics, 1978
- Salivary levels of anticonvulsantsNeurology, 1977
- Protein Binding and Kinetics of Drugs in Liver DiseasesClinical Pharmacokinetics, 1977
- Use of saliva in monitoring carbamazepine medication in epileptic childrenEuropean Journal of Nuclear Medicine and Molecular Imaging, 1977
- SIGNIFICANCE OF SIMULTANEOUS DETERMINATION OF CARBAMAZEPINE AND ITS 10,11-EPOXIDE FROM PLASMA AND HUMAN ERYTHROCYTES1977
- Carbamazepine and its 10,11-epoxide in children and adults with epilepsyEuropean Journal of Clinical Pharmacology, 1977
- Pharmacokinetic Data of Carbamazepine and Its Major Metabolites in ManPublished by Springer Nature ,1975